Southeast Asset Advisors, LLC

Position in NVS — Novartis AG

CIK 1390003 Thomasville, GA

Position in NVS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,052,531

+$26,662 QoQ

Shares Held

6,716

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.12%

of 13F equity value

Holder Rank

#603

of 1,602 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Southeast Asset Advisors, LLC holds $26,273,942 across 7 Drug Manufacturers - General names. NVS ranks #6 (4.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	45,781	$11,627,000
2	ABBV	AbbVie Inc.	21,450	$5,397,678
3	LLY	ELI LILLY & Co	2,848	$3,415,976
4	PFE	Pfizer Inc	99,468	$2,395,189
5	MRK	Merck & Co., Inc.	12,706	$1,632,721
6	NVS	Novartis AG This page	6,716	$1,052,531
7	AMGN	Amgen Inc	2,079	$752,847

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,052,531	6,716	0.0%	Shares	Sole	2026-08-14
2026-03-31	$1,025,869	6,716	+3.5%	Shares	Sole	2026-05-13
2025-12-31	$894,914	6,491	0.0%	Shares	Sole	2026-02-13
2025-09-30	$832,405	6,491	+13.5%	Shares	Sole	2025-11-07
2025-06-30	$692,177	5,720	+118.3%	Shares	Sole	2025-08-12
2025-03-31	$292,077	2,620	0.0%	Shares	Sole	2025-05-14
2024-12-31	$254,952	2,620	0.0%	Shares	Sole	2025-02-13
2024-09-30	$301,352	2,620	0.0%	Shares	Sole	2024-11-13
2024-06-30	$278,925	2,620	-2.4%	Shares	Sole	2024-08-12
2024-03-31	$259,623	2,684	0.0%	Shares	Sole	2024-05-14
2023-12-31	$271,003	2,684	0.0%	Shares	Sole	2024-02-13
2023-09-30	$273,392	2,684	—	Shares	Sole	2023-11-14
No filing history on record for this holder in this stock.